Temasek unit trims Celltrion holdings in $1bn block duo
Singapore sovereign wealth fund Temasek Holdings has raised W1.07tr ($1bn) after offloading stock in South Korean pharmaceutical company Celltrion and its distribution arm Celltrion Healthcare in a pair of overnight block sales.
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article: